Hangzhou, China

Gengshen Song

This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hangzhou Tianlong Pharmaceutical Co., Ltd., Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gengshen Song. Retrieved from https://idiyas.com/inventor/gengshen-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gengshen Song: Innovator in mRNA Vaccine Development

Introduction

Gengshen Song is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of mRNA vaccines. With a total of 5 patents to his name, Song is recognized for his innovative approaches to vaccine technology.

Latest Patents

Among his latest patents are groundbreaking developments in the realm of mRNA vaccines. His notable inventions include the "Respiratory Syncytial Virus mRNA Vaccine, and Preparation Method Therefor and Use Thereof" and the "Herpes Zoster mRNA Vaccine, Preparation Method Therefor, and Use Thereof." These patents reflect his commitment to advancing medical science and improving public health.

Career Highlights

Gengshen Song is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. His work at this esteemed company has positioned him at the forefront of vaccine research and development. His innovative contributions have garnered attention within the scientific community and beyond.

Collaborations

Throughout his career, Song has collaborated with notable colleagues, including Huanyu Wang and Kai Dong. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective work in the field of biotechnology.

Conclusion

Gengshen Song's contributions to mRNA vaccine development exemplify the spirit of innovation in the biotechnology sector. His patents and collaborations highlight the importance of teamwork in advancing medical research. As he continues to push the boundaries of science, his work will undoubtedly have a lasting impact on public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…